Johnson & Johnson (JNJ) Gets a Buy Rating from Leerink Partners
December 01 2021 - 03:06AM
TipRanks
In a report issued on November 19, Danielle Antalffy from Leerink
Partners maintained a Buy rating on Johnson & Johnson (JNJ –
Research Report), with a price target of $200.00. The company's
shares closed last Tuesday at $155.93. According to TipRanks.com,
Antalffy is a 4-star analyst with an average return of 11.9% and a
52.2% success rate. Antalffy covers the Healthcare sector, focusing
on stocks such as Axonics Modulation Technologies, Inspire Medical
Systems, and Treace Medical Concepts. Currently, the analyst
consensus on Johnson & Johnson is a Strong Buy with an average
price target of $195.00, which is a 23.0% upside from current
levels.
https://www.tipranks.com/news/blurbs/johnson-johnson-jnj-gets-a-buy-rating-from-leerink-partners?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2022 to Aug 2022
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2021 to Aug 2022